跳至主要内容
临床试验/NCT06517784
NCT06517784已完成不适用

Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 752 人开始时间: 2024年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
752
试验地点
1
主要终点
The barriers toward insulin initiation among HCPs & patients

研究概览

简要总结

This is a cross-sectional study planned among patients with Type 2 Diabetes (T2D) and Health Care Providers (HCPs) who treat T2D patients. Study participants will be recruited through existing databases/panels to complete a 30-minute self-administered online survey. The purpose of the study is to understand the insulinization barriers and the insulin adherence behaviours of both HCPs and patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For patients
  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 18 years at the time of signing informed consent.
  • Diagnosed with T2D
  • Currently seeing an HCP for T2D
  • Initiated on insulin within the past 12 months
  • Prescribed insulin on a permanent basis
  • Currently taking insulin via a vial and syringe or insulin pen
  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, age above or equal to 18 years at the time of signing informed consent.
  • Primary care physician (PCP) with degree in internal medicine or general medicine, diabetologist with degree in internal medicine or general medicine plus diploma in diabetology, or endocrinologist
  • Has been in practice a minimum of 2 years
  • Diabetologist/endocrinologist: treats at least 50 T2D patients per month
  • PCP: treats at least 40 T2D patients per month
  • Currently initiates T2D patients on insulin
  • Treats 20 percent or more of T2D patients with insulin

排除标准

  • Previous participation in this study. Participation is defined as having given informed consent in this study
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

结局指标

主要结局

The barriers toward insulin initiation among HCPs & patients

时间窗: At time of data abstraction (Day 1)

Barriers to insulin initiation = Likert scale: 1=Strongly disagree, 5=Strongly agree

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Insulin Initiation and Adherence Behaviours: a Cross... | 临床试验